MPK10 Antibody

Shipped with Ice Packs
In Stock

Description

Biological Context of MPK10

MPK10 is a member of the MAP kinase family involved in:

  • Plant development: Regulation of endosperm growth via cross-inhibition with transcription factor WRKY10 in Arabidopsis

  • Parasite differentiation: Stage-specific activation during Leishmania amastigote development, critical for host adaptation

Key Applications of MPK10 Antibody

ApplicationExperimental ContextKey Findings
Co-immunoprecipitation (Co-IP)Arabidopsis endosperm studiesConfirmed physical interaction between MPK10 and WRKY10 using GFP-tagged constructs
Kinase Activity AssaysLeishmania axenic amastigotesQuantified stage-specific MPK10 activation via radioactive MBP phosphorylation assays
Subcellular LocalizationDual-luciferase assays in N. benthamianaIdentified MPK10-mediated suppression of WRKY10 transcriptional activity

Regulatory Mechanisms

  • Auto-inhibition: In Leishmania, MPK10’s C-terminal domain (aa 368–485) suppresses kinase activity until environmental triggers (e.g., pH/temperature shifts) relieve this inhibition .

  • Cross-species conservation: Despite 90%+ sequence identity in Leishmania species, functional divergence exists in plant vs. parasite systems .

Functional Insights

  • Plant studies:

    • mpk10 mutants showed 2.5-fold increased WRKY10 expression (2DAP seeds, P < 0.01) .

    • MPK10 knockdown led to 18% larger seeds due to deregulated endosperm expansion .

  • Parasite studies:

    • Hyperactive MPK10 (ΔC-terminal 46aa) caused 70% cell death during amastigote differentiation .

    • Phospho-serine 395 was identified as a critical regulatory residue for kinase activity .

Technical Considerations for MPK10 Antibodies

ParameterRequirement
SpecificityMust distinguish phosphorylated (TxY motif) vs. inactive forms
Species ReactivitySeparate antibodies needed for plant (Arabidopsis) vs. protozoan (Leishmania) targets
ValidationRequires knockout controls (e.g., mpk10 mutants) to confirm signal absence

Challenges and Future Directions

  • Limitations: No commercial MPK10 antibodies are explicitly cited in current literature; most studies use epitope-tagged proteins (e.g., GFP/Flag) .

  • Opportunities:

    • Develop phospho-specific antibodies to study MPK10 activation dynamics.

    • Explore therapeutic targeting of Leishmania MPK10 in visceral leishmaniasis .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
MPK10 antibody; At3g59790 antibody; F24G16.60 antibody; Mitogen-activated protein kinase 10 antibody; AtMPK10 antibody; MAP kinase 10 antibody; EC 2.7.11.24 antibody
Target Names
MPK10
Uniprot No.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.